Janupally Renuka

737 total citations
26 papers, 611 citations indexed

About

Janupally Renuka is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Janupally Renuka has authored 26 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Infectious Diseases and 10 papers in Organic Chemistry. Recurrent topics in Janupally Renuka's work include Cancer therapeutics and mechanisms (21 papers), Tuberculosis Research and Epidemiology (16 papers) and Synthesis and biological activity (6 papers). Janupally Renuka is often cited by papers focused on Cancer therapeutics and mechanisms (21 papers), Tuberculosis Research and Epidemiology (16 papers) and Synthesis and biological activity (6 papers). Janupally Renuka collaborates with scholars based in India. Janupally Renuka's co-authors include Dharmarajan Sriram, Perumal Yogeeswari, Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, Shalini Saxena, Priyanka Suryadevara, Pushkar Kulkarni, Vijay Soni, Raghavender Medishetti and Srihari Konduri and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Organic & Biomolecular Chemistry.

In The Last Decade

Janupally Renuka

26 papers receiving 608 citations

Peers

Countries citing papers authored by Janupally Renuka

Since Specialization

Citations

This map shows the geographic impact of Janupally Renuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janupally Renuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janupally Renuka more than expected).

Fields of papers citing papers by Janupally Renuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janupally Renuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janupally Renuka. The network helps show where Janupally Renuka may publish in the future.

Co-authorship network of co-authors of Janupally Renuka

This figure shows the co-authorship network connecting the top 25 collaborators of Janupally Renuka. A scholar is included among the top collaborators of Janupally Renuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janupally Renuka. Janupally Renuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors 2016 ·European Journal of Medicinal Chemistry ·Variam Ullas Jeankumar, R. Reshma, Rahul Vats, Janupally Renuka, Shalini Saxena, Perumal Yogeeswari, Dharmarajan Sriram	27
2	Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain 2015 ·Bioorganic & Medicinal Chemistry ·Shalini Saxena, Ganesh Samala, Janupally Renuka, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram	21
3	4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation 2015 ·European Journal of Medicinal Chemistry ·(unknown), Priyanka Suryadevara, Janupally Renuka, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram	42
4	Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase 2015 ·Journal of Molecular Graphics and Modelling ·(unknown), Shalini Saxena, Janupally Renuka, Vijay Soni, Perumal Yogeeswari, Diógenes Santiago Santos, Cristiano Valim Bizarro, Dharmarajan Sriram	16
5	Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors 2015 ·International Journal of Mycobacteriology ·(unknown), Janupally Renuka, Jonnalagadda Padma Sridevi, (unknown), (unknown), Perumal Yogeeswari, Dharmarajan Sriram	26
6	Design and synthesis of novel quinoline–aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors 2015 ·Bioorganic & Medicinal Chemistry ·(unknown), Janupally Renuka, Shalini Saxena, Jonnalagadda Padma Sridevi, Raghavender Medishetti, Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	48
7	Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: A study against active, dormant and resistant tuberculosis 2015 ·European Journal of Pharmaceutical Sciences ·Jonnalagadda Padma Sridevi, Priyanka Suryadevara, Janupally Renuka, (unknown), Vijay Soni, (unknown), Perumal Yogeeswari, Dharmarajan Sriram	11
8	Polymer–gold nanoparticle composite films for topical application: Evaluation of physical properties and antibacterial activity 2015 ·Polymer Composites ·(unknown), Suman Labala, (unknown), Janupally Renuka, Dharmarajan Sriram, Venkata Vamsi Krishna Venuganti	19
9	Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis 2014 ·European Journal of Medicinal Chemistry ·(unknown), Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, Shalini Saxena, Parthiban Brindha Devi, Janupally Renuka, Perumal Yogeeswari, Dharmarajan Sriram	26
10	Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus 2014 ·Bioorganic & Medicinal Chemistry ·Janupally Renuka, Variam Ullas Jeankumar, (unknown), Vijay Soni, Parthiban Brindha Devi, (unknown), Priyanka Suryadevara, (unknown), Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	18
11	An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition 2014 ·Bioorganic & Medicinal Chemistry ·(unknown), Srihari Konduri, Janupally Renuka, (unknown), (unknown), Variam Ullas Jeankumar, Jonnalagadda Padma Sridevi, (unknown), Perumal Yogeeswari, Dharmarajan Sriram	38
12	Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: Hit to lead optimization of a novel class of thiazole inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·Variam Ullas Jeankumar, (unknown), Janupally Renuka, Priyanka Suryadevara, Jonnalagadda Padma Sridevi, Raghavender Medishetti, Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	22
13	Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure‐Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues 2014 ·ChemMedChem ·Variam Ullas Jeankumar, Janupally Renuka, (unknown), Shalini Saxena, (unknown), Jonnalagadda Padma Sridevi, (unknown), Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	12
14	Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling 2014 ·Organic & Biomolecular Chemistry ·Variam Ullas Jeankumar, R. Reshma, Janupally Renuka, Shalini Saxena, Jonnalagadda Padma Sridevi, (unknown), Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	24
15	Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation 2014 ·Molecular Informatics ·Shalini Saxena, Janupally Renuka, Perumal Yogeeswari, Dharmarajan Sriram	15
16	Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: Pharmacophore mapping from known antibacterial leads 2014 ·European Journal of Medicinal Chemistry ·(unknown), Janupally Renuka, Variam Ullas Jeankumar, (unknown), Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram	9
17	ChemInform Abstract: Synthesis and Evaluation of 1‐Cyclopropyl‐6‐fluoro‐1,4‐dihydro‐4‐oxo‐7‐(4‐(2‐ (4‐substitutedpiperazin‐1‐yl)acetyl)piperazin‐1‐yl) quinoline‐3‐carboxylic Acid Derivatives as Antitubercular and Antibacterial Agents. 2014 ·ChemInform ·Suresh Narva, (unknown), Janupally Renuka, Vikrant Singh Rajput, (unknown), Inshad Ali Khan, Kondapalli Venkata Gowri Chandra Sekhar	1
18	Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents 2013 ·European Journal of Medicinal Chemistry ·Suresh Narva, (unknown), Janupally Renuka, Vikrant Singh Rajput, Rashmi Sharma, Inshad Ali Khan, Kondapalli Venkata Gowri Chandra Sekhar	38
19	Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: Scaffold hopping from known antibacterial leads 2013 ·International Journal of Antimicrobial Agents ·Variam Ullas Jeankumar, Janupally Renuka, (unknown), Vijay Soni, Jonnalagadda Padma Sridevi, Priyanka Suryadevara, Shravan Morla, Raghavender Medishetti, Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	32
20	Thiazole–aminopiperidine hybrid analogues: Design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors 2013 ·European Journal of Medicinal Chemistry ·Variam Ullas Jeankumar, Janupally Renuka, (unknown), Vijay Soni, Jonnalagadda Padma Sridevi, Priyanka Suryadevara, Perumal Yogeeswari, Dharmarajan Sriram	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact